dc.contributor.author
Zhong, Cheng
dc.contributor.author
Schleifenbaum, Johanna
dc.date.accessioned
2019-08-06T12:05:37Z
dc.date.available
2019-08-06T12:05:37Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/25233
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-3938
dc.description.abstract
Hypertension is ranked as the third cause of disability-adjusted life-years. The percentage of the population suffering from hypertension will continue to increase over the next years. Renovascular disease is one of the most common causes of secondary hypertension. Vascular changes seen in hypertension are partially based on dysfunctional calcium signaling. This signaling can be studied using calcium indicators (loading dyes and genetically encoded calcium indicators; GECIs). Most progress in development has been seen in GECIs, which are used in an increasing number of publications concerning calcium signaling in vasculature and the kidney. The use of transgenic mouse models expressing GECIs will facilitate new possibilities to study dysfunctional calcium signaling in a cell type-specific manner, thus helping to identify more specific targets for treatment of (renal) hypertension.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
hypertension
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Genetically Encoded Calcium Indicators: A New Tool in Renal Hypertension Research
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
128
dcterms.bibliographicCitation.doi
10.3389/fmed.2019.00128
dcterms.bibliographicCitation.journaltitle
Frontiers in Medicine
dcterms.bibliographicCitation.originalpublishername
Frontiers Media S.A.
dcterms.bibliographicCitation.volume
6
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31263699
dcterms.isPartOf.eissn
2296-858X